Syncom Formulations (India) Limited Reported Its Excellent Performance For 4th Quarter

Share via:


Mumbai (Maharashtra) [India], June 2: Syncom Formulation ( India ) Ltd , a Speciality Pharmaceutical Formulation company Today reported its excellent performance for 4th quarter and year ended 31st March 25. 

Q4 FY2025 Performance highlights (compared to Q4 FY2024): 

  • Revenue from operations at Rs.14888 Lacs against Rs.7457 Lacs.; up 100%. 
  • EBITDA at Rs.2469 Lacs against Rs.1252 Lacs; Up 97%; 
  • Profit after tax at Rs.1769 Lacs against Rs.740 Lacs.; Up 139%;

FY 2025 Performance highlights (compared to FY2024): 

  • Revenue from…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Syncom Formulations (India) Limited Reported Its Excellent Performance For 4th Quarter


Mumbai (Maharashtra) [India], June 2: Syncom Formulation ( India ) Ltd , a Speciality Pharmaceutical Formulation company Today reported its excellent performance for 4th quarter and year ended 31st March 25. 

Q4 FY2025 Performance highlights (compared to Q4 FY2024): 

  • Revenue from operations at Rs.14888 Lacs against Rs.7457 Lacs.; up 100%. 
  • EBITDA at Rs.2469 Lacs against Rs.1252 Lacs; Up 97%; 
  • Profit after tax at Rs.1769 Lacs against Rs.740 Lacs.; Up 139%;

FY 2025 Performance highlights (compared to FY2024): 

  • Revenue from…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

New hardware launching at WWDC? Here’s what the latest...

WWDC kicks off Monday with Apple’s big keynote...

Nandan Nilekani Doles Out Second Grant To AI4Bharat

SUMMARY With this, Nilekani has pumped INR 70 Cr...

Indha: Redefining Sustainability Through Design Innovation; Training Rural Women...

New Delhi , June 6: In a world increasingly...

Popular

Upcoming Events

asdasdas asdasdas asdasdas asdasdas asdasdas asdasdas asdasdas asdasdas